LexDanaLexDanabeta
Inventor

Zhihua Ma

Inventor
Lexington, MA, US

Overview

24→
Patents
2008–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds15%
C07BGeneral methods of organic chemistry10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
PatentTitleYear
10,736,883Triazole furan compounds as agonists of the APJ receptor202010,689,367Triazole pyridyl compounds as agonists of the APJ receptor202010,221,162Triazole agonists of the APJ receptor201910,150,760Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor201810,058,550Methods of treating heart failure20189,988,369Heterocyclic triazole compounds as agonists of the APJ receptor20189,868,721'Triazole agonists of the APJ receptor'20189,845,310Intermediates for preparing triazole agonists of the APJ receptor20179,751,864'Methods for preparing triazole agonists of the APJ receptor'20179,745,286'Triazole agonists of the APJ receptor'20179,656,998'Intermediates for preparing triazole agonists of the APJ receptor'20179,656,997'Triazole agonists of the APJ receptor'20179,593,129'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20179,573,936'Triazole agonists of the APJ receptor'20179,376,425'Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer'20169,296,736'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20168,748,462'Spirocyclic GPR40 modulators'20148,003,648'Heterocyclic GPR40 modulators'20117,816,367'Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders'20107,714,008'Heterocyclic GPR40 modulators'20107,687,526'Benzo-fused compounds for use in treating metabolic disorders'20107,649,110'Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders'20107,582,803'Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders'20097,465,804'Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders'2008

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2008–2020Patents assigned to AMGEN INC (24)· patent assignee history
2008–2011Based in San Mateo, CA, US· patent location history
2014Patents assigned to BROWN SEAN P (1)· patent assignee history
2014Patents assigned to DRANSFIELD PAUL (1)· patent assignee history
2014Patents assigned to DU XIAOHUI (1)· patent assignee history
2014Patents assigned to FU ZICE (1)· patent assignee history
2014–2016Based in Foster City, CA, US· patent location history
2017–2020Based in Lexington, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMGEN INC242008–2020
BROWN SEAN P12014
DRANSFIELD PAUL12014
DU XIAOHUI12014
FU ZICE12014
Locations
LocationPatentsSpan
Lexington, Massachusetts, US142017–2020
San Mateo, California, US72008–2011
Foster City, California, US32014–2016